Linda P. Briley - Concepedia

Concepedia

Author

Linda P. Briley

Research Triangle Park Foundation

Also Known As

L P Briley, L. Briley, L. P. Briley, L.P. Briley, Linda Briley, Linda P Briley, Linda P. Briley

32

Publications

1.2K

Citations

12

H-Index

49

Concepts

All Affiliations

Research Triangle Park Foundation GlaxoSmithKline (United Kingdom)GlaxoSmithKline (United States)University of North Carolina at Chapel Hill Age UK

LP

About

Linda P. Briley is an author at Research Triangle Park Foundation specializing in medicine, genetics, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	708
2	Public Health	4	4	589
3	Natural Sciences	2	2	70
4	Cell Biology	2	2	70
5	Biostatistics	1	1	51

Linda P. Briley

×

13

Publications

1.2K

Citations

12

H-Index

	Year	Citations
The Population Reference Sample, POPRES: A Resource for Population, Disease, and Pharmacological Genetics Research Matthew R. Nelson, Katarzyna Bryc, Karen S. King, The American Journal of Human Genetics Genetic AnalysisPharmacological Genetics ResearchGenotype-phenotype AssociationMedicineGenetics	2008	332
<i>HLA-DQA1</i> * <i>02:01</i> Is a Major Risk Factor for Lapatinib-Induced Hepatotoxicity in Women With Advanced Breast Cancer Colin F. Spraggs, L. R. Budde, Linda P. Briley, Journal of Clinical Oncology	2011	274
Genomewide Search for Type 2 Diabetes Susceptibility Genes in Four American Populations Margaret G. Ehm, Maha Karnoub, H. Sakul, The American Journal of Human Genetics Genome-wide Association StudyGenetic DeterminantDiabetes EpidemiologyGeneticsDiabetes	2000	194
<i>HLA-B</i> *57:01 Confers Susceptibility to Pazopanib-Associated Liver Injury in Patients with Cancer Chun‐Fang Xu, Toby Johnson, Xiaojing Wang, Clinical Cancer Research	2015	95
Comprehensive genome-wide evaluation of lapatinib-induced liver injury yields a single genetic signal centered on known risk allele HLA-DRB1*07:01 Laura R. Parham, Linda P. Briley, L Li, The Pharmacogenomics Journal	2015	60
Defective bypass replication of a leading strand cyclobutane thymine dimer in xeroderma pigmentosum variant cell extracts. D L Svoboda, Linda P. Briley, J M Vos PubMed Dna DamageGeneticsMolecular BiologyDermatologyEpigenetics	1998	54
Case‐control single‐marker and haplotypic association analysis of pedigree data Sharon R. Browning, J. D. Briley, Linda P. Briley, Genetic Epidemiology GeneticsGenetic EpidemiologyLinkage AnalysisLinkage StudiesGenome-wide Association Studies	2004	51
Mortality, kidney disease and cardiac procedures following acute coronary syndrome Jula K. Inrig, Uptal D. Patel, Linda P. Briley, Nephrology Dialysis Transplantation	2007	44
Characterisation of the HLA-DRB1*07:01 biomarker for lapatinib-induced liver toxicity during treatment of early-stage breast cancer patients with lapatinib in combination with trastuzumab and/or taxanes Colin F. Spraggs, Laura R. Parham, Linda P. Briley, The Pharmacogenomics Journal Breast OncologyHepatologyMedicineLiver PhysiologyLapatinib-induced Liver Toxicity	2017	20
Reparative strand incision in saponin-permeabilized human fibroblasts William K. Kaufmann, Linda P. Briley Mutation Research/DNA Repair Reports FibrosisWound HealingDermatologyMatrix BiologyMedicine	1987	18

Page 1